You are here: Home » European Pharmaceutical Review magazine » Past issues » Industry Focus 2010
You must be a member to access this exclusive content!
Silver membership gives you:
- Exclusive access to every article from our back issue archive
- Our regular email newsletter
Or become a subscriber and also get:
- Six issues of European Pharmaceutical Review (printed magazine)
Join now >>
Industry Focus 2010
Industry Focus 2010 / 22 February 2010 /
LGC is an international science-based company located in South West London. A progressive and innovative enterprise, LGC operates in socially responsible fields underpinning the health, safety and security of the public, and regulation and enforcement for UK government departments and blue chip clients. Our products and services enable our customers to have a sound basis on which to base their scientific and commercial decisions or conformity to international statutory and regulatory standards. (more…)
Tagged with: Daniel J Scott, Genomics, Jim Huggett, LGC
Industry Focus 2010 / 22 February 2010 /
Over the past decade we have seen a significant realignment of activities associated with drug discovery and this will continue for a multitude of reasons. Within the pharmaceutical industry we have seen significant changes e.g. a decrease in the numbers of drugs that are being approved by the regulatory authorities and the looming expiration of patented drugs, both of which have an immediate and direct consequence on revenue streams. In light of these issues, the pharmaceutical industry is responding appropriately. These changes have included a re-assessment of the strategies being employed in the pre-clinical phase of drug discovery, some of which are discussed in relation to automation solutions. (more…)
Tagged with: European ScreeningPort, Lab Automation, Sheraz Gul
Industry Focus 2010 / 22 February 2010 /
It would be fair to say that these past 12 months have been a watershed year for stem cell science. In years to come we may look back on 2009 and recognise it as the year in which nascent areas of science, medicine and technology came together to slowly nudge stem cell biology into the mainstream. Scientific and academic progress aside, it also may mark the year in which the field first matured to a stage at which commercial viability came to the cusp of realisation. (more…)
Tagged with: GE Healthcare, Stem Cells, Stephen Minger
Industry Focus 2010 / 22 February 2010 /
For decades microbiological quality has remain dormant while the pharmaceutical industry has continued to evolve. Compendial methods and limits, while now generally harmonised throughout the world, still reflect the same methods utilised 100 years ago. Although there is more clarification around the number and types of organisms permitted in products since routes of administration are better defined, there is little change to what is considered an acceptable number or the types of organisms allowed in product. The good news is, however, in this new environment of Quality by Design (QbD) and the Process Analytical Technology Initiative1 outlined in Quality for the 21st Century, application of a Risk Based approach can provide some flexibility for microbial control. Through an enhanced understanding of the product and process gained during product development, some of the repetitive and inefficient end product testing may be replaced with real time or supportive data to confirm microbial quality. (more…)
Tagged with: GlaxoSmithKline, GSK, Linda Skowronsky, Microbiology
Industry Focus 2010 / 22 February 2010 /
The Centre for Process Analytics and Control Technology (CPACT) is a unique industry-driven multi-disciplinary research and development club that was formed in 1997 by the Departments of Pure and Applied Chemistry at the University of Strathclyde, the Department of Chemical and Process Engineering at the University of Newcastle and the Department of Chemistry at the University of Hull, together with 18 member companies. (more…)
Tagged with: David Littlejon, Julian Morris, PAT, Perceptive Engineering Ltd, Roger Benson, Strathclyde University
Login to access exclusive content